European Study of 24,195 axSpA pts shows that 1st TNFi resulted in 27% ASDAS inactive disease @6 months & 59% achieved BASDAI <40; 80% continued Rx after 1 year. 1178 patients w/ non-radiographic axSpA had lower 12-mos retention (73%) https://t.co/KJn5eD6wWw
Links:
Treatment response and drug retention rates in 24 195 biologic-naïve patients w…
https://buff.ly/2zg2dj5
Aug-23-2019
